Session 1: Matrix remodeling in lung disease 08:45-09:05 Matrix dysfunction in COPD Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro Marko Nikolic, Cambridge, United Kingdom 10:25-10:50 Coffee break 10:50-11:05 OP03 -Time-resolved proteomic characterization of ECM remodelling in human lung scaffold cultures using stable isotope labelling Oskar Rosmark, Lund, Sweden 11:05-11:25 Extracellular matrix anisotropy in cancer invasion and metastasis Danielle Park, London, United Kingdom 11:25-11:40 Discussion 11:40-11:55 OP04 -The activation of MET-driven invasive growth in IPF and metastasis is modulated by different mechanisms of cell/matrix interaction Coffee 16:45-18:45 Poster Session 1 PP101 -Serological assessment of different proteolytic fragments of elastin predicts mortality differently in the ECLIPSE COPD cohort -Sarah Rønnow, Herlev, Denmark PP102 -Allergen-activated eosinophils impact on expression of extracellular matrix proteins in airway smooth muscle cells during asthma -Ieva Janulaityte, Kaunas, Lithuania PP103 -Cyclical stretch induces transforming growth factor-ß signalling via Gaq/11 in lung fibroblasts, but does not increase myofibroblast differentiation -Amanda Goodwin, Nottingham, United Kingdom PP104 -Synthetic lethality of KRAS-mutant tumor cells in vivo depends on inflammatory signaling to myeloid cells -Kristina Arendt, Munich, Germany PP105 -Airway epithelial-to-mesenchymal transition: compartmentalized cyclic AMP -Haoxiao Zuo, Groningen, Netherlands PP106 -AKT1/AKT2 mRNA balance Is significantly different in IPF BAL cells compared to other fibrotic ILDs -Eliza Tsitoura, Heraklion, Greece PP107 -Age associated changes in extracellular matrix proteins in the lung are also present in severe COPD -Corry-Anke Brandsma, Groningen, Netherlands PP108 -MicroRNAs regulate genome-wide post-transcriptional gene expression in severe asthma bronchial epithelium as determined by Frac-seq -Rocio Teresa Martinez-Nunez, London, United Kingdom PP109 -Trp53 signaling in lung adenocarcinoma -Maria Oplopoiou, Rion, Greece PP110 -Anti-diabetic drug metformin imposes anti-fibrotic effects by controlling fibroblast plasticity -Vahid Kheirollahi -Giessen, Germany PP111 -Material properties of lung scaffolds derived from healthy and IPF donor tissues are associated with disease pathology -Linda Elowsson, Lund, Sweden PP112 -Fluid shear stress modulates changes in eosinophil morphology prior to transmigration -Kiho Son, Hamilton, Canada PP113 -Differential effect of ARDS on alveolar macrophage efferocytosis compared to bacterial phagocytosis -Rahul Mahida, Birmingham, United Kingdom PP114 -miR449 protects airway cilia and healthy lung ageing -Muriel Lizé, Göttingen, Germany PP115 -IL-33 signaling contributes to pollutant-induced allergic airway inflammation -Tania Maes, Ghent, Belgium PP116 -Physical and biochemical interactions drive fibrocytes accumulation in the scleroderma lung matrix -Huanxing Sun, New Haven, USA PP117 -p16Ink4a deletion reverses adult consequences of experimental bronchopulmonary dysplasia, and promotes fibrosis -Maeva Zysman, Vincennes, France PP118 -Analysis of Emilin-2 functions in lung injury and repair -Maximilian Strunz, Munich, Germany PP119 -Spontaneous extracellular matrix turnover in PCLS from COPD patients -Carmel Nanthakumar, Hertfordshire, United Kingdom PP120 -Hepatocyte growth factor regulates lung mesenchymal stem cell transition from quiescence to active state in the bleomycin injured lung -Kleanthis Fytianos, Bern, Switzerland PP121 -Glycosaminoglycans differ in amount and modification dependent on disease severity in COPD -Oskar Hallgren, Lund, Sweden PP122 -Phosphoproteomics reveals the signaling landscape of lung fibroblast rigidity sensing -Laura Wanat, Munich, Germany PP123 -Global proteomics analysis reveals altered lung extracellular matrix composition following resolution of influenza virus infection -Oliver Brand, Manchester, United Kingdom PP124 -CCAAT/enhancer binding protein delta (C/EBPd) deficiency does not affect bleomycininduced pulmonary fibrosis -Jan Willem Duitman, Paris, France PP125 -Ghrelin expression in mast cells of infant lung with respiratory distress syndrome -Koni Ivanova, Stara Zagora, Bulgaria PP126 -Investigating the phosphorylation of mTOR (S2448) as a novel biomarker for TGF-ß1 signalling -Matthew Redding, Bedfordshire, United Kingdom PP127 -Mechanical preconditioning of lung-derived mesenchymal stem cells improves ventilation-induced lung injury in rats -Isaac Almendros, Barcelona, Spain PP128 -Extracellular matrix composition of decellularized emphysematous and control lung tissue -Danique J. Hof, Nijmegen, Netherlands PP129 -The dynamics of tumor-stroma interactions in lung cancer -Magdalena Szczygiel, Heidelberg, Germany PP130 -TGF-ß increases IL-33 expression by primary human lung fibroblasts -Katherine Stephenson, Nottingham, United Kingdom PP131 -Bronchial extracellular matrix from COPD patients induces altered gene expression in repopulated primary human bronchial epithelial cells -Xiaohong Zhou, Molndal, Sweden PP132 -Azithromycin reduces aSMA and leads to vacuolar formation in lung fibroblasts -Ronja Schliep, Hannover, Germany PP133 -Nuclear factor κΒ-signalling drives Malignant Pleural Mesothelioma -Ioanna Giopanou, Rio, Greece PP134 -Generation of alveolar epithelial cells from human induced pluripotent stem cells for a model of alveolar wound repair -Sander van Riet, Leiden, Netherlands PP135 -Characterization of Lung Resident Mesenchymal Stem Cells in patients with COPD -Sandra Casas, Barcelona, Spain PP136 -Implication of ADAM10 protease in malignant mesothelioma -Christelle Sepult, Liège, Belgium PP137 -In vivo models of Drug Induced ILD; tools to study and improve drug safety -Irma Mahmutovic Persson, Lund, Sweden PP138 -The impact of cannabis smoke on lung surfactant performance -Mike Davies, Liverpool, United Kingdom PP139 -The composition and the interaction between lung fibroblasts and alveolar-epithelial cells with the surrounding matrix is crucial in pulmonary fibrosis -Carlos Esteban Machahua, Barcelona, Spain PP140 -Microfibrillar-associated protein 4 promotes experimental asthma by modulation of airway smooth muscle cell phenotype -Bartosz Pilecki, Odense, Denmark PP141 -Macrophage inflammatory tolerance and elevated hyaluronan a microRNA signature after resolution of an infection -Sylvia Lui, Manchester, United Kingdom
